ImmunoPrecise Antibodies Ltd. Net Asset Quality Index
ImmunoPrecise Antibodies Ltd. net asset quality index. ImmunoPrecise Antibodies Ltd. (HYFT) has a Net Asset Quality Index of 67.8% as of October 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $26.10 Million minus total liabilities of $8.40 Million yields net assets of $17.70 Million. A higher index indicates a stronger, lower-leverage balance sheet. See HYFT book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of ImmunoPrecise Antibodies Ltd. (1997–2025)
Net asset quality index of ImmunoPrecise Antibodies Ltd. from 1997 to 2025. This chart shows how ImmunoPrecise Antibodies Ltd.'s Net Asset Quality Index has evolved across 29 annual periods from 1997 to 2025. As of October 2025, the index stands at 67.8%, representing net assets of $17.70 Million against total assets of $26.10 Million USD. Check asset allocation strategy of ImmunoPrecise Antibodies Ltd. to assess the company's strategic physical and investment asset allocation.
ImmunoPrecise Antibodies Ltd. Net Asset Quality Index by Year (1997–2025)
ImmunoPrecise Antibodies Ltd. net asset quality index by year from 1997 to 2025. The table below presents the year-by-year Net Asset Quality Index for ImmunoPrecise Antibodies Ltd. from 1997 to 2025, covering 29 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ImmunoPrecise Antibodies Ltd. (HYFT) market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 53.2% | $23.63 Million | $44.44 Million | $20.82 Million | ▼ -3.4 pp |
| 2024 | 56.5% | $33.92 Million | $59.99 Million | $26.07 Million | ▼ -17.7 pp |
| 2023 | 74.3% | $57.80 Million | $77.81 Million | $20.01 Million | ▼ -6.1 pp |
| 2022 | 80.4% | $75.13 Million | $93.49 Million | $18.36 Million | ▼ -4.7 pp |
| 2021 | 85.0% | $56.92 Million | $66.96 Million | $10.04 Million | ▲ +29.7 pp |
| 2020 | 55.3% | $15.09 Million | $27.26 Million | $12.18 Million | ▼ -8.4 pp |
| 2019 | 63.7% | $18.07 Million | $28.35 Million | $10.28 Million | ▲ +12.1 pp |
| 2018 | 51.7% | $12.70 Million | $24.58 Million | $11.87 Million | ▼ -27.0 pp |
| 2017 | 78.7% | $3.09 Million | $3.93 Million | $836.91K | ▲ +12.9 pp |
| 2016 | 65.8% | $908.26K | $1.38 Million | $472.15K | ▲ +517.9 pp |
| 2015 | -452.2% | $-208.52K | $46.12K | $254.64K | ▼ -338.9 pp |
| 2014 | -113.3% | $-161.21K | $142.29K | $303.50K | ▲ +318.2 pp |
| 2013 | -431.5% | $-215.66K | $49.97K | $265.63K | ▼ -302.9 pp |
| 2012 | -128.6% | $-119.89K | $93.22K | $213.10K | ▼ -188.2 pp |
| 2011 | 59.6% | $125.81K | $211.00K | $85.19K | ▼ -38.5 pp |
| 2010 | 98.2% | $5.37 Million | $5.47 Million | $100.47K | ▲ +0.3 pp |
| 2009 | 97.8% | $6.78 Million | $6.93 Million | $150.84K | ▼ -1.4 pp |
| 2008 | 99.3% | $5.12 Million | $5.16 Million | $37.46K | ▲ +2.1 pp |
| 2007 | 97.2% | $5.40 Million | $5.56 Million | $155.85K | ▲ +0.6 pp |
| 2006 | 96.6% | $3.91 Million | $4.05 Million | $138.62K | ▼ -2.3 pp |
| 2005 | 98.9% | $4.23 Million | $4.28 Million | $47.18K | ▲ +2.4 pp |
| 2004 | 96.5% | $1.39 Million | $1.44 Million | $49.92K | ▼ -1.7 pp |
| 2003 | 98.3% | $912.21K | $928.23K | $16.02K | ▲ +19.6 pp |
| 2002 | 78.7% | $691.56K | $879.28K | $187.72K | ▲ +56.0 pp |
| 2001 | 22.6% | $262.24K | $1.16 Million | $896.75K | ▼ -74.9 pp |
| 2000 | 97.5% | $396.53K | $406.64K | $10.11K | ▼ -0.3 pp |
| 1999 | 97.8% | $1.62 Million | $1.66 Million | $35.78K | ▲ +0.1 pp |
| 1998 | 97.7% | $2.86 Million | $2.93 Million | $67.39K | ▲ +4.1 pp |
| 1997 | 93.6% | $3.63 Million | $3.88 Million | $250.04K | — |